Vesencumab (Synonyms: MNRP-1685A) |
| Catalog No.GC70116 |
Vesencumab (MNRP-1685A) is an IG1 antibody targeting neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and blocks its coupling with VEGFR-2. Vesencumab has antiangiogenic and antitumor activity. Vesencumab can be used for research on metastatic solid tumors, including ovarian cancer.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1205533-60-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Vesencumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Vesencumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *